Cicada COVID-19 Variant: Symptoms, Spread, and Key Facts

While the atmosphere across St. Louis usually shifts toward the excitement of spring—with crowds gathering around the Gateway Arch and families planning trips to Forest Park—there is a quiet, clinical concern brewing in the background of our local healthcare conversations. The news of the “Cicada” COVID-19 variant, scientifically known as BA.3.2, has begun to filter through the medical community here in Missouri. For most of us, the pandemic feels like a distant chapter of history, but as we’ve learned over the last few years, the virus possesses a stubborn ability to reinvent itself just as we feel we’ve moved past it.

The arrival of BA.3.2 is not a sudden explosion of cases, but rather a unhurried, calculated emergence. In Missouri, doctors are currently tracking the variant with a watchful eye, though confirmed cases within the state remain limited. However, the nature of this specific strain is what has public health officials on edge. Unlike previous variants that followed a predictable evolutionary path, the Cicada variant is what experts describe as “hyper-mutated.” It doesn’t just change; it transforms in ways that develop it gaze fundamentally different to our immune systems.

The Science of the ‘Cicada’ Mutation

To understand why this variant is receiving a specific nickname and high-level monitoring, one has to look at the genetic architecture of the virus. According to Andrew Pekosz, Ph.D., a virologist at the Johns Hopkins Bloomberg School of Public Health, BA.3.2 possesses a significant number of mutations in its spike protein. The spike protein is essentially the “key” the virus uses to unlock and enter human cells; It’s as well the primary target that our vaccines and natural antibodies recognize.

When the spike protein undergoes a “slew of genetic changes,” the immune system—primed by previous infections or vaccinations—may no longer recognize the “key.” This potential for immune evasion is the primary driver behind the World Health Organization (WHO) classifying BA.3.2 as a “variant under monitoring” back in December 2025. The variant’s behavior is mirrored in its name. T. Ryan Gregory, Ph.D., a professor of evolutionary biology at the University of Guelph, coined the name “Cicada” as the variant spent its early existence “underground,” emerging slowly before gaining traction globally.

This pattern of emergence is a reminder of the ongoing volatility of respiratory viruses. For residents in the St. Louis metro area, staying informed means understanding that while the current threat level is managed, the genetic distance between BA.3.2 and earlier strains suggests we cannot rely solely on outdated immunity. This is why staying current with community health guidelines is more critical than ever.

Tracking the Spread: From South Africa to Missouri

The journey of BA.3.2 began far from the Midwest. It was first detected in a respiratory sample from South Africa on November 22, 2024. For nearly a year, it simmered in the background, but by September 2025, detections peaked across 23 different countries. By the time it reached the United States, the Centers for Disease Control and Prevention (CDC) began spotting it through a combination of clinical samples and, more importantly, environmental monitoring.

The detection of Cicada in the U.S. Highlights the power of the National Wastewater Surveillance System (NWSS). This program allows health officials to spot the presence of a variant in a community before people even start showing up at clinics. In the U.S., BA.3.2 has been detected in 25 states, including Missouri. Other states reporting its presence through the NWSS include California, New York, Florida, and Rhode Island, among others. The WastewaterSCAN system has flagged the variant in states like Ohio and Michigan, showing a broader regional spread across the Midwest.

In the local context of Missouri, the strategy is one of vigilant observation. Because the variant has been found in wastewater but clinical cases remain low, health providers are in a “detect and track” phase. This early warning system is designed to prevent the kind of sudden surges that characterized the early 2020s, allowing hospitals and clinics to prepare their resources well in advance.

Why Wastewater Monitoring Matters for St. Louis

For those living in the city, it’s easy to ignore a virus if you aren’t feeling sick, but wastewater data provides a transparent, objective map of what is actually circulating in our pipes. When the CDC identifies BA.3.2 in nasal swabs from travelers or airplane wastewater, it signals an entry point. When it appears in community sewage, it signals local transmission. This data-driven approach allows us to maintain a level of public safety awareness without needing to return to the restrictive measures of the past.

Local Health Resource Guide: Navigating the Cicada Variant

Given my background in geo-journalism and health policy analysis, I’ve seen how national news can create unnecessary panic or, conversely, dangerous complacency. If you are concerned about the BA.3.2 variant and how it might affect your family or business in the St. Louis area, you shouldn’t rely on general internet searches. You need specific types of local expertise to navigate this “hyper-mutated” landscape.

If this trend begins to impact your local circle, here are the three categories of professionals Consider prioritize when seeking guidance:

Comprehensive Primary Care Providers

Rather than visiting an urgent care center for every sniffle, establish a relationship with a primary care physician who has a strong tie to local health networks. Look for providers who are actively integrated with the Missouri Department of Health’s reporting systems. You want a doctor who can distinguish between the common seasonal flu and the specific markers of a mutated strain like BA.3.2, ensuring you get the correct diagnostic test rather than a generic screen.

Board-Certified Infectious Disease Specialists

For individuals who are immunocompromised or have chronic respiratory issues, a general practitioner may not be enough. You should seek out infectious disease specialists—often affiliated with major regional medical centers—who specialize in viral evolution and vaccine efficacy. When hiring or consulting with these specialists, inquire specifically about their experience with “immune-evasive” variants and their current protocols for treating heavily mutated SARS-CoV-2 strains.

Corporate Occupational Health Consultants

For St. Louis business owners, the goal is to keep the workforce healthy without disrupting operations. Instead of guessing at safety protocols, engage an occupational health consultant. Look for professionals who specialize in “Environmental Health and Safety” (EHS) and have a track record of implementing wastewater-informed safety plans. They can help you create a flexible response plan that triggers only when local CDC data shows a genuine increase in variant prevalence, avoiding unnecessary workplace anxiety.

Ready to identify trusted professionals? Browse our complete directory of top-rated healthcare providers in the st. Louis area today.